This clinical validation study leverages the expertise of BioAgile Therapeutics, D2R Global Consulting, and Milann Fertility Hospitals. It will provide crucial data on the SemSure Kit’s performance and potential to revolutionize rapid semen detection in both forensic and personal health applications. The study’s comprehensive approach and involvement of leading organizations in the field ensure a thorough evaluation of this innovative diagnostic tool.

Problem Statement
1. General Sexual Wellness:
• There is a lack of easy-to-access, reliable options for women to confirm suspected exposure to semen, which is crucial for making informed reproduc6ve health decisions.
• Current at-home semen detection options are non-existent, forcing women to rely on unpredictable outcomes or repeated use of emergency contraception.
• There is a need for a rapid, accurate, and convenient testing solution to empower women to promptly obtain emergency contraception and make other time-sensitive choices about their sexual health.